$1.57
0.021.29%
At close: -
$1.50
-0.07-4.46%
After Hours: 4:12 PM EDT
Comments
Loading...
Salarius Pharmaceuticals (SLRX) Forecast
NewsEarningsSalarius Pharmaceuticals (SLRX) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestSalarius Pharmaceuticals (NASDAQ:SLRX) Stock Quotes, Forecast and News Summary
Salarius Pharmaceuticals Stock (NASDAQ: SLRX) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Salarius Pharmaceuticals (SLRX) stock?
You can purchase shares of Salarius Pharmaceuticals (NASDAQ:SLRX) through any online brokerage.
Who are Salarius Pharmaceuticals (SLRX) competitors?
Other companies in Salarius Pharmaceuticals’s space includes: ZyVersa Therapeutics (NASDAQ:ZVSA), Dermata Therapeutics (NASDAQ:DRMA), Bone Biologics (NASDAQ:BBLG), Quoin Pharmaceuticals (NASDAQ:QNRX) and Qualigen Therapeutics (NASDAQ:QLGN).
What is the forecast, or price target, for Salarius Pharmaceuticals (SLRX) stock?
Salarius Pharmaceuticals has a consensus price target of $4.00.
What is the current price for Salarius Pharmaceuticals (SLRX)?
The stock price for Salarius Pharmaceuticals (NASDAQ: SLRX) is $1.5 last updated December 23, 2024 at 4:12 PM EST.
Does Salarius Pharmaceuticals (SLRX) pay a dividend?
There are no upcoming dividends for Salarius Pharmaceuticals.
When is Salarius Pharmaceuticals (NASDAQ:SLRX) reporting earnings?
Salarius Pharmaceuticals’s Q4 earnings are confirmed for Friday, March 21, 2025.
Is Salarius Pharmaceuticals (SLRX) going to split?
There is no upcoming split for Salarius Pharmaceuticals.
What sector and industry does Salarius Pharmaceuticals (SLRX) operate in?
Salarius Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.